An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune ...

Active pharmaceutical ingredients (APIs), including both small molecules and biologic compounds, are often encapsulated in microspheres and nanoparticles. This encapsulation is utilized for specific ...

Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine ...

Scientists at Xi’an Jiaotong-Liverpool University (XJTLU) and at Nanjing University have combined a widely used medical polymer with a natural blood protein to develop a new nanoparticle drug delivery ...

A new nanoparticle made from the medical polymer PLGA and the blood protein albumin can carry higher doses of drugs and remain stable longer, offering improved delivery and fewer side effects. For ...